grant

Development of Sensitive and Specific Proteomic Biomarkers of Aging, Health, Frailty, and Morbidity in Human and Mouse Cohorts

Organization NATIONAL INSTITUTE ON AGINGLocation UNITED STATES
NIHUS FederalResearch GrantFY2025AgingBaltimoreBiological AgingBiological MarkersBloodBlood PlasmaBlood Reticuloendothelial SystemBlood SerumBlood monocyteBody TissuesCaloric RestrictionCirculationClinicalCohort StudiesCollectionComplexConcurrent StudiesConduct Clinical TrialsCoupledData CollectionDevelopmentDiagnosticDiseaseDisorderEvaluationFutureGeneticGeroscienceGoalsHealthHumanInterventionIntervention StudiesIntervention TrialInterventional trialLongitudinal StudiesMarrow monocyteMeasuresMiceMice MammalsModelingModern ManMorbidityMorbidity - disease rateMurineMusObesityOutcomePathway interactionsPhenotypePhysiologicPhysiologicalPlasmaPlasma SerumProteinsProteomicsPublishingRapamuneRapamycinResearchReticuloendothelial System, Serum, PlasmaSamplingSenotherapeuticSerumSirolimusSurrogate End PointsSurrogate EndpointTestingTissuesTranslationsWorkadiposityage associatedage associated declineage clockage correlatedage dependentage dependent declineage linkedage relatedage related declineage specificaged groupaged groupsaged individualaged individualsaged peopleaged personaged personsaged populationaged populationsaging associatedaging biological markeraging biomarkeraging clocksaging markeraging populationaging preventionaging relatedanti aginganti geronicantiagingbio-markersbiologic markerbiological agebiological process of agebiomarkerbiomarker signatureblood-based biomarkerblood-based markercalorie restrictioncirculating biomarkerscirculating markersclinical phenotypeclock measuring biological ageclock measuring biological agingclock of biological agingcohortcorpulencedecline with agedevelopmentalfrailtygeroscientifichuman modelintervention researchinterventional researchinterventional studyinterventions researchlong-term studylongitudinal outcome studiesminimally invasivemodel of humanmonocytemortalitymouse modelmultimorbiditymultiomicsmultiple chronic conditionsmultiple omicsmurine modelnano particlenano-sized particlenanoparticlenanosized particlenew approachesnovelnovel approachesnovel strategiesnovel strategyobese individualsobese peopleobese personobese populationobese subjectsoutcome predictionpanomicspathwaypopulation agingprevent age relatedprevent agingprogramsproteomic signaturesenescencesenescentsexsuppress agingtooltranslationtreatment strategy
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

To overcome the technical challenges associated with plasma proteomics, we developed workflows that utilize nanoparticle-based enrichment coupled with MS enabled comprehensive characterization of plasma and serum samples with high dynamic range. the secretome from senescent monocytes in culture in serum-supplemented culture conditions. Our…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Development of Sensitive and Specific Proteomic Biomarkers of Aging, Health, Frailty, and Morbidity in Human and Mouse C | Dev Procure